Roth/MKM Starts OS Therapies, Inc (OSTX) at Buy, PT $7, 'Durable Survival Supports OST-HER2 Approval'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/13/2026

1. CSCO
2. CBRS
3. COHR
4. SPY
5. NVDA
6. WYFI
7. STUB
8. EAT
9. BTGO
10. GO

Go back to Roth/MKM Starts OS Therapies, Inc (OSTX) at Buy, PT $7, 'Durable Survival Supports OST-HER2 Approval'
(NYSE: OSTX) Delayed: 1.60 -0.01 (0.62%)
Previous Close $1.61    52 Week High $ 
Open $1.59    52 Week Low $ 
Day High $1.61    P/E N/A 
Day Low $1.54    EPS $ 
Volume 573,303